Punit Dhillon
Chief Executive Officer at Skye Bioscience Inc.
Sits on 1 board. Last updated September 27, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Skye Bioscience Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Skye Bioscience Inc. May 26, 202698.3%
-
Skye Bioscience Inc. June 6, 202590.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 7, 2026 | Skye Bioscience Inc. | Grant or award | +1,090,000 | — | — |
| Nov 18, 2024 | Skye Bioscience Inc. | Open-market sale | −82,546 | $4.99 | $411,905 |
| Nov 15, 2024 | Skye Bioscience Inc. | Open-market sale | −364 | $5.55 | $2,020 |
| Aug 26, 2024 | Skye Bioscience Inc. | Other | +15,727 | — | — |
| Feb 29, 2024 | Skye Bioscience Inc. | Grant or award | +100,000 | — | — |
| Nov 6, 2023 | Skye Bioscience Inc. | Grant or award | +194,270 | — | — |
| Aug 29, 2023 | Skye Bioscience Inc. | Open-market purchase | +881,000 | $0.02 | $17,620 |
| Aug 28, 2023 | Skye Bioscience Inc. | Small acquisition | +110,000 | $0.02 | $2,200 |
| Aug 25, 2023 | Skye Bioscience Inc. | Grant or award | +20,277,414 | — | — |
| Aug 23, 2023 | Skye Bioscience Inc. | Small acquisition | +9,000 | $0.01 | $90 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.